The drug existed.
It simply never arrived.
BrandLaunchX was founded by Abhijit Sengupta following a deeply personal experience. He lost a loved one to illness despite effective treatments being available. The drugs had been approved. The science had worked. But the launch had not reached the markets where those treatments were needed.
After two decades as a senior executive at AstraZeneca and Novartis, watching the same pattern repeat across dozens of launches, Abhi built the platform he wished had existed.
“We have the scientific capability to develop these therapies. We need the operational capability to deliver them.”
Abhijit Sengupta, Founder & CEO, BrandLaunchX
of therapeutic launches underperform commercial expectations
Early modelling and market assessmentcost of a single day’s launch delay to a pharmaceutical company
Industry benchmarkinginterdependent teams that must coordinate across a modern therapeutic launch
BrandLaunchX analysisin annual industry value lost to launch underperformance
IQVIA market forecasting
